Launching a new drug in India, whether a completely new molecule or a generic one, has become a herculean task. The Supreme Court's recent dictat that the government review 157 clinical trials has delayed fresh approvals.
first published: Mar 5, 2014 09:52 pm
A collection of the most-viewed Moneycontrol videos.
